Leveraged Finance & Private Equity Communities Unite To Rais…

(MENAFN- Caribbean News International)

NEW YORK–(Small business WIRE)–On Thursday, June 16, 2022, far more than 900 men and women from above 100 companies from the leveraged finance and personal equity communities arrived together for the Leveraged Finance Fights Melanoma (LFFM) advantage and cocktail party. Hosted at the Museum of Fashionable Art, the occasion raised a report breaking $3 million for the Melanoma Exploration Alliance’s (MRA) mission to progress the world’s most progressive and promising melanoma research.

“Each 12 months, I carry on to be amazed by the community’s reaction to this celebration and the mission it supports,” says LFFM co-founder and MRA board member Jeff Rowbottom.“LFFM has come to be a signature celebration for the finance industry, and it plays a important function in advancing cancer study that is practically preserving lives, such as mine.”

LFFM funding supports chopping-edge melanoma exploration that has aided people with all sorts of cancer are living for a longer period, fuller life. Remedies initially pioneered in melanoma are now remaining made use of to address individuals with over 30 other cancer forms.

LFFM was established in 2011 by Jeff Rowbottom (Iron Park Capital) and Brendan Dillon (Veritas Capital) – the two melanoma survivors. Because its founding, LFFM has raised more than $19 million for MRA, the biggest nonprofit funder of melanoma analysis. Considering the fact that its founding in 2007, MRA-funded investigators have been deeply associated in each individual breakthrough in melanoma investigate, including the approval of 15 new therapies.

The party was co-chaired by Clare Bailhé (MidCap Fiscal), Brendan Dillon (Veritas Capital), Kerry Dolan (Brinley Companions), Lee Grinberg (Elliott Administration), Matt Manin (Apollo), George Mueller (KKR), Geoff Oltmans (Silver Lake), Kevin Pluff , Jeff Rowbottom (Iron Park Funds), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), Trevor Watt (Hellman & Friedman), and Eric Wedel (Kirkland & Ellis).

Presenting sponsors of the party incorporated Latham & Watkins, Kirkland & Ellis, Simpson Thacher & Bartlett, Fitch Rankings, Michael Milken, HPS Investment Partners, Apollo|Midcap, Iron Park Capital Administration, Veritas Cash Management and White & Circumstance. A complete record of LFFM sponsors is incorporated beneath.

“The leveraged finance and non-public fairness communities are some of the biggest advocates for MRA and our mission to get rid of melanoma,” says MRA CEO Marc Hurlbert, PhD.“The money lifted from this celebration will even more accelerate the MRA exploration agenda and the continuation of more rapidly cures, new treatments and lifesaving breakthroughs.

LFFM 2022 Sponsors

PRESENTING

Kirkland & Ellis

Latham & Watkins

Simpson Thacher & Bartlett LLP

Michael Milken

Apollo|Midcap

Fitch Scores

HPS Investment decision Partners, LLC

Iron Park Cash

Veritas Cash Administration LLC

White & Circumstance LLP

PLATINUM

Allen & Overy

BMO Cash Marketplaces

Davis Polk & Wardwell

Joyce and Barry Cohen

Shearman & Sterling LLP

Sidley Austin LLP

UBS Money

GOLD

Bank of The us Merrill Lynch

Barclays Capital

Bloomberg L.P.

Brinley Associates

Citi

Typical Atlantic Philanthropic Foundation

Golub Capital

Hellman & Friedman

Intesa Sanpaolo

King & Spalding LLP

KKR

Leonard Environmentally friendly & Companions

Howard and Nancy Marks

Milbank LLP

MJR Basis

Morgan Stanley

New Mountain Finance Company

Proskauer Rose

Ropes & Gray LLP

Silver Lake

Sixth Street Companions

Skadden, Arps, Slate, Meagher & Flom LLP

T. Rowe Selling price

TD Securities

The Carlyle Team

Thoma Bravo

Vista Fairness Associates

Weil, Gotshal & Manges LLP

Wells Fargo Financial institution

Chosen

Jefferies LLC

Credit Suisse

GTCR

Royal Bank of Canada/RBC Cash Markets

American Industrial Partners

Ares Administration LLC

BC Associates

Blackstone Credit history

Blue Owl Money

BNP Paribas

Centerbridge Partners

Clayton, Dubilier & Rice LLC

Cleary Gottlieb Steen & Hamilton

Cravath, Swaine & Moore LLP

Debevoise & Plimpton

Deutsche Financial institution

Fried, Frank, Harris, Shriver & Jacobson LLP

HIG Capital

HSBC Lender

Macquarie Team

Madison Dearborn Partners

Matt Nord and Erika Weinberg

Mizuho Securities United states of america, Inc.

MJX Asset Management LLC

MUFG

Oak Hill Advisors, LP

Oak Hill Money Administration

Silver Rock Monetary

Stone Canyon Industries

Stone Issue Cash

Sullivan & Cromwell LLP

Wachtell, Lipton, Rosen & Katz

Winston & Strawn

ADVOCATE

Fortinbras

Tiger Worldwide

Introduction Worldwide Corporation

Angelo Gordon & Co.

BlackRock

Brookfield Asset Administration

Funds Just one Bank

Clarion Capital Partners, LLC

GoldenTree Asset Administration, LP

Lauren Hanrahan

Houlihan Lokey

LSTA

Natixis

Orchard Initial Source Asset Management

Paul Hastings LLP

PNC Lender

Riverstone

Rothschild & Co.

Seix Expense Advisors

Shenkman Capital Management Inc.

Siris Money Group

Stonepeak Partners

Sumitomo Mitsui Banking Corporation (SMBC)

Stephanie Teicher

Warburg Pincus LLC

Z Funds Group

About Melanoma Exploration Alliance (MRA)

The Melanoma Investigation Alliance (MRA) stands as the premier non-earnings funder of melanoma analysis. Launched in 2007, MRA’s mission is to stop suffering and dying owing to melanoma by advancing the world’s most promising science and investigation. MRA presents significant funding for melanoma cancer investigate that propels improvements in prevention, prognosis, therapy, metastasis, and survivorship. MRA-funded researchers have been guiding every breakthrough in melanoma study. Because MRA’s inception, more than 15 new therapeutic techniques for melanoma have gained Food and drug administration approval. MRA is recognized as a person of the most fiscally productive non-revenue in the nation. For the reason that MRA’s Founders’ generously include 100% of MRA’s administrative and operating prices, each dollar donated is invested immediately into MRA’s scientific and investigate plan. For far more data, please check out: .

LinkedIn: melanoma-investigation-alliance

Twitter: @MelanomaReAlli

Instagram: @melanoma

Facebook: MelanomaResearchAlliance

Contacts

Cody R. Barnett, Director of Communications

M: (717) 880-7100

E-mail:

Additional Media Contacts:
Anreder & Firm

917.923.7011
Steven S. Anreder —
Michael Wichman —

MENAFN17062022000232011072ID1104392577

&#13
Legal Disclaimer: MENAFN gives the information and facts “as is” devoid of guarantee of any form. We do not settle for any duty or legal responsibility for the accuracy, information, images, movies, licenses, completeness, legality, or dependability of the info contained in this posting. If you have any problems or copyright concerns similar to this article, kindly contact the provider higher than. &#13